.common-hero

.mfg-section

The Emerald building is the registered office of the Pfizer Healthcare India Pvt Ltd and a Global Service Centre that houses Global Biometrics and Data Management, Global Regulatory Sciences divisions, World-Wide Safety functions. It is located in Chennai, India and is spread over an area of about 98,000 sq ft - covering 7 floors. The Site is also supported by a robust team of Finance, Digital, Legal and People Experience functions

Global Biometrics and Data Management

Global Regulatory Sciences

Worldwide Safety

Global Services

#product-develop

Global Biometrics and Data Management

PHIPL Global Biometrics and Data Management (GBDM) supports clinical and late stage development of medicines and regulatory sciences across all therapeutic areas. It plays an important role in executing to the mandate of delivering the global portfolio. Our associates bring science and data analytics together to support various aspects of the drug development process, from clinical trial execution, data acquisition, data review, statistical analysis and reporting, regulatory sciences and submissions. Most of our GBDM associates are located in Chennai and Mumbai.

We work in an open work environment that fosters collaboration and enables teams to translate advanced science and technologies into breakthrough innovations and therapies, in order to bring Breakthroughs That Change Patients’ Lives.

Global Product Development

#regulatory-sci

Global Regulatory Sciences Global Regulatory Sciences

Global Regulatory Sciences

PHIPL Global Regulatory Sciences (GRS) delivers safe, effective, and quality Products to patients worldwide. A diverse regulatory talent pool of professionals supports Regulatory Strategy (Global, Regional & Country) and Global Regulatory Operations (GRO) for Pfizer Biopharmaceutical Group comprising of Innovative Medicines Business and Hospital Business Unit.

Regulatory Strategy teams of PHIPL support new Registrations from Concept-to-Commercialization and post approval Life-Cycle Maintenance of On-Market products in partnership with R&D, Pfizer Global Supply, Commercial, Global & Regional Regulatory teams. Multiple Regulatory Strategy teams (Chemistry Manufacturing Controls (CMC) & Non-CMC) are grouped by Platforms, Portfolios (Sterile Injectables Generics, Brands, Biologics & Biosimilars) and Therapeutic Areas.

Regulatory Operations teams of PHIPL support End-to-End Dossier Execution through multiple teams across Submissions Management, Publishing and Product License Support, Artwork Implementation, and, Labeling Process Management, thereby enabling regulatory submissions and global strategy.

#worldwide-safety

Worldwide Safety

Patient safety is the foundation for everything Pfizer is doing. For more than a century, taking care of patients and their well-being has been at the core of what we do every day. Medical Excellence, Regulatory Compliance and Operational Excellence are the three pillars of drug safety.

The Worldwide Safety team is responsible for conducting all strategic and operational aspects of pharmacovigilance, from early development through submission and onto post approval. Colleagues from more than 50 countries work together to collect, understand, assess and prevent adverse effects or any other possible drug-related problems and to contribute to a robust understanding of benefit/risk profiles across the portfolio.

The Worldwide Safety functional lines in PHIPL work together to collect, analyze, and draw conclusions from safety events to inform the understanding of the safe and effective use of our medicines by patients.

Worldwide Safety Worldwide Safety

#global-services